Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Combination of abciximab with primary stenting in patients with acute myocardial infarction: A community hospital experience
Autore:
Arjomand, H; Mascarenhas, DAN;
Indirizzi:
Med Coll Penn & Hahnemann Univ, Easton Hosp, Dept Med, Easton, PA USA Med Coll Penn & Hahnemann Univ Easton PA USA p, Dept Med, Easton, PA USA
Titolo Testata:
JOURNAL OF INVASIVE CARDIOLOGY
fascicolo: 3, volume: 12, anno: 2000,
pagine: 125 - 129
SICI:
1042-3931(200003)12:3<125:COAWPS>2.0.ZU;2-T
Fonte:
ISI
Lingua:
ENG
Soggetto:
CORONARY-ARTERY DISEASE; BALLOON ANGIOPLASTY; IMMEDIATE ANGIOPLASTY; THROMBOLYTIC THERAPY; PILOT TRIAL; BLOCKADE; IMPLANTATION; INSIGHTS; PTCA;
Keywords:
abciximab; coronary stents; c7E3; myocardial infarction; primary coronary angioplasty;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
35
Recensione:
Indirizzi per estratti:
Indirizzo: Mascarenhas, DAN 123 S 22nd St, Easton, PA 18042 USA 123 S 22nd St EastonPA USA 18042 , Easton, PA 18042 USA
Citazione:
H. Arjomand e D.A.N. Mascarenhas, "Combination of abciximab with primary stenting in patients with acute myocardial infarction: A community hospital experience", J INVAS CAR, 12(3), 2000, pp. 125-129

Abstract

dAbciximab administration during primary coronary angioplasty in patients with acute myocardial infarction (AMI) reduces death, reinfarction, and theneed for urgent target vessel revascularization (TVR). Stenting in AMI reduces the rate of repeat in-hospital TVR, There is Limited information on the effectiveness and one-year clinical event rate of combined abciximab and primary stenting in patients with AMI at community hospitals. We evaluated the outcome of 40 consecutive patients treated with both abciximab and primary stenting at our institution, All patients underwent primary stenting ofthe infarct-related artery. All patients received abciximab, aspirin, ticlopidine, and heparin, TIMI grade 3 flow was established in all 40 patients. No patient required urgent TVR, There was no in-hospital reinfarction or cardiac-related death. All patients were followed for at least one year, andno patient died after hospital discharge. Thallium exercise stress test revealed no evidence of ischemia at 12-months follow-up. We conclude that combined abcisimab and primary stenting in this series of patients with AMI was associated with excellent results.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/05/20 alle ore 14:59:22